Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
44 studies found for:    0815
Show Display Options
Rank Status Study
1 Completed Relapse Prevention With Varenicline
Conditions: Recurrence;   Smoking Cessation;   Substance-Related Disorders
Interventions: Drug: Varenicline;   Drug: Placebo
2 Completed
Has Results
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Drug: Sorafenib;   Drug: Erlotinb
3 Completed Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Embryonal Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Metastatic Childhood Soft Tissue Sarcoma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Visual Pathway Glioma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride;   Other: pharmacological study
4 Recruiting Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
Conditions: Stable Coronary Artery Disease;   Obesity;   Impaired Glucose Tolerance
Interventions: Other: training;   Other: training + metformin;   Other: training + glitazon
5 Recruiting Enhancement of Hand Motor Function After Cervical Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Procedure: High frequency non-invasive repetitive transcranial magnetic stimulation;   Procedure: Sham rTMS over control brain area
6 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
7 Terminated Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
8 Terminated Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Condition: Melanoma
Intervention:
9 Completed Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BDP/formoterol NEXT DPI
10 Completed A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: 5 counselor-delivered sessions;   Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
11 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
12 Completed Hypopituitarism After Aneurismal Subarachnoid Hemorrhage
Conditions: Aneurismal Subarachnoid Hemorrhage;   Hypopituitarism;   Neuropsychological Deficits
Intervention:
13 Unknown  Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Condition: Hepatic Neoplasm Malignant Recurrent
Interventions: Drug: NIK-333(peretinoin);   Drug: Placebo
14 Unknown  Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Procedure: therapeutic conventional surgery
15 Completed Comparison of Insulin Mix25 Versus Mix50
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Lispro Mix25;   Drug: Insulin Lispro Mix50
16 Completed A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: continuous infusion of 5-fluorouracil;   Drug: combination of irinotecan and cisplatin;   Drug: oral administration of S-1
17 Unknown  A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
Condition: Small-Cell-Lung Cancer
Interventions: Drug: Etoposide and cisplatin after chemoradiotherapy;   Drug: Irinotecan and cisplatin after chemoradiotherapy
18 Completed
Has Results
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: gemcitabine;   Drug: cisplatin
19 Not yet recruiting A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: LY2157299;   Drug: Sorafenib
20 Unknown  A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
Condition: Colorectal Neoplasms
Interventions: Drug: 5FU+l-leucovorin;   Drug: UFT+Leucovorin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years